Physician profile
Nirav M Patel
NPI 1588042600
$6,530.98
in general payments reported to CMS, 2019-2025
19 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $374 · 2021: $631 · 2022: $27.30 · 2023: $919 · 2024: $3,205 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,659 · Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,658.55 |
| Food and Beverage | $1,858.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,250.16 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $2,087.69 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $947.34 | 2023-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Stryker Corporation | $554.88 | 2024 | Augment Injectable |
| Nevro Corp. | $248.90 | 2023-2024 | Senza |
| Abbott Laboratories | $119.20 | 2023-2025 | Eterna, Proclaim |
| Avanos Medical | $89.25 | 2025 | Generator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.13 | 2023 | Relistor |
| Azurity Pharmaceuticals, INC. | $23.19 | 2025 | Horizant |
| Abbvie INC. | $21.72 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.56 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.56 | 2024 | |
| Biotronik Nro, INC. | $16.52 | 2025 | Prospera |
| Globus Medical, INC. | $16.19 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $15.67 | 2023 | Ztlido |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.47 | 2020 | |
| Hikma Pharmaceuticals USA | $14.23 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.07 | 2022 | |
| Si-Bone, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.